GlassScriptPhysician profile
Subhash K Reddy
NPI 1821068511
$2,175.99
in general payments reported to CMS, 2019-2025
18 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $52.88 · 2021: $336 · 2022: $325 · 2023: $542 · 2024: $292 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $654.08 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $290.93 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $276.32 | 2019-2024 | |
| Pfizer INC. | $274.85 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $156.15 | 2021-2023 | Verquvo |
| Intuitive Surgical, INC. | $114.98 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $90.34 | 2022-2023 | Camzyos |
| Allergan, INC. | $78.49 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.12 | 2022 | |
| Sunovion Pharmaceuticals INC. | $35.70 | 2019 | |
| Gilead Sciences, INC. | $33.45 | 2021 | |
| Esperion Therapeutics, INC. | $26.73 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $23.34 | 2022 | |
| Philips North America LLC | $19.20 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.48 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $14.11 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $12.99 | 2021 | |
| Amneal Pharmaceuticals LLC | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subhash Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.